Lung cancer can become resistant to chemotherapy and thus may evolve into poor clinical outcome; a frequently involved mechanism in multidrug resistance (MDR) is the overexpression of the previously mentioned P-glycoprotein (P-gp, MDR1), which may be the target of MDR modulators. The gene discussed is ABCB1; the disease is lung cancer.